Correlation Between Burning Rock and Sutro Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Burning Rock and Sutro Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Burning Rock and Sutro Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Burning Rock Biotech and Sutro Biopharma, you can compare the effects of market volatilities on Burning Rock and Sutro Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Burning Rock with a short position of Sutro Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Burning Rock and Sutro Biopharma.

Diversification Opportunities for Burning Rock and Sutro Biopharma

-0.87
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Burning and Sutro is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Burning Rock Biotech and Sutro Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sutro Biopharma and Burning Rock is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Burning Rock Biotech are associated (or correlated) with Sutro Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sutro Biopharma has no effect on the direction of Burning Rock i.e., Burning Rock and Sutro Biopharma go up and down completely randomly.

Pair Corralation between Burning Rock and Sutro Biopharma

Considering the 90-day investment horizon Burning Rock Biotech is expected to generate 0.9 times more return on investment than Sutro Biopharma. However, Burning Rock Biotech is 1.11 times less risky than Sutro Biopharma. It trades about 0.04 of its potential returns per unit of risk. Sutro Biopharma is currently generating about -0.29 per unit of risk. If you would invest  695.00  in Burning Rock Biotech on October 6, 2024 and sell it today you would earn a total of  10.00  from holding Burning Rock Biotech or generate 1.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Burning Rock Biotech  vs.  Sutro Biopharma

 Performance 
       Timeline  
Burning Rock Biotech 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Burning Rock Biotech are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Burning Rock reported solid returns over the last few months and may actually be approaching a breakup point.
Sutro Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sutro Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Burning Rock and Sutro Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Burning Rock and Sutro Biopharma

The main advantage of trading using opposite Burning Rock and Sutro Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Burning Rock position performs unexpectedly, Sutro Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sutro Biopharma will offset losses from the drop in Sutro Biopharma's long position.
The idea behind Burning Rock Biotech and Sutro Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators